TCTR20230713008Enrolling By Invitation3 期
The efficacy of adding branched-chain amino acid supplement with home-based exercise for treatment of sarcopenia in cirrhotic patients
/A0 个研究点目标入组 10 人开始时间: 2023年7月13日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- Enrolling By Invitation
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 70 Years（—）
- 性别
- All
入选标准
- •Any cause cirrhotic patient with CTP atleast 7
- •Sarcopenia by Computer Tomography scan
排除标准
- •Severe comorbid disease: ESRD,uncontrol DM,COPD,CHF,ACS,cancer
- •HIV infection, AIDS
- •Liver or kidney transplant
- •HCC beyond Milan Criteria
- •History of TIPS
- •Uncontrol ascites, EV, GV, Jaundice
- •Hepatic encephalopathy
- •Current alcohol drinking
- •Hospitalization due to severe bacterial infection
- •Receive BCAA within 6 months
- •Severe orthopedic problems limiting possibility to exercise
- •Patient refuse
研究者
相似试验
已完成
不适用
Effect of branched-chain amino acids supplementation for patients with non alcoholic fatty liver diseasenonalcoholic fatty liver diseaseJPRN-UMIN000012351Kagoshima University Hospital, Center for Gastroenterology, Gastroenterological Medicine15
尚未招募
1 期
Branched Chain Amino Acid and Muscle mass in Chronic Liver DiseaseCTRI/2020/05/025459Indian Council of Medical Research
Enrolling By Invitation
4 期
Effect of branched-chain amino acid supplements on frailty liver index in patients with liver cirrhosisBranched-chain amino acid supplements will improved frailty index in patients with all stage of cirrhosis.Branched-chain amino acid supplement , liver frailty indexTCTR20210928001Thammasat University52
尚未招募
2 期
The effect of branched-chain amino acid granules to innate immunity in decompensated cirrhosis, A randomized controlled trialLiver CirrhosisDecompensated cirrhosis,Child-Pugh B,C with documented ascitesand MELD score < 20Amino Acids,Branched-ChainImmunity,InnateTCTR20190830005Faculty of Medicine, Prince of Songkla University72
尚未招募
不适用
Effect of Branch Chain Amino Acid therapy on muscle mass in children with chronic liver diseaseCTRI/2021/11/038012ILBS